Utreloxastat 是一种用于研究包括 α-突触核蛋白病、tau 蛋白病、ALS、创伤性脑损伤和缺血再灌注相关损伤在内的疾病的化合物。

Utreloxastat is a compound used for the research of the disorders including α-synucleinopathies, tauopathies, Amyotrophic lateral sclerosis (ALS), traumatic brain injury, and ischemic-reperfusion related injuries (patent WO2020081879A2, example A1) [1].

1213269-96-5

C18H28O2

276.41

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years